{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:52:28Z","timestamp":1792068748923,"version":"4.4.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.vaccine.2008.06.021","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T17:41:45Z","timestamp":1221068505000},"page":"K17-K28","source":"Crossref","is-referenced-by-count":300,"special_numbering":"S10","title":["Epidemiology of Human Papillomavirus Infection in Men, Cancers other than Cervical and Benign Conditions"],"prefix":"10.1016","volume":"26","author":[{"given":"Anna R.","family":"Giuliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Tortolero-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann N.","family":"Burchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"de Sanjose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne Kruger","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nubia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Xavier","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.06.021_bib1","unstructured":"IARC. Human Papillomavirus. IARC Monographs on the Evaluation of carcinogenic risk to humans. Vol. 90. Lyon: IARC Press, 2007."},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.021_bib2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00042560-200103010-00007","article-title":"Detection of genetic changes in anal intraepithelial neoplasia (AIN) of HIV-positive and HIV-negative men","volume":"26","author":"Haga","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"23","key":"10.1016\/j.vaccine.2008.06.021_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.jncimonographs.a024166","article-title":"Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women","author":"Palefsky","year":"1998","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.021_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/318071","article-title":"Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women","volume":"183","author":"Palefsky","year":"2001","journal-title":"J Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2008.06.021_bib5","first-page":"3839","article-title":"Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants","volume":"58","author":"Xi","year":"1998","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.vaccine.2008.06.021_bib6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/00002030-199810000-00010","article-title":"Effect of HIV infection on the natural history of anal human papillomavirus infection","volume":"12","author":"Critchlow","year":"1998","journal-title":"AIDS"},{"issue":"15","key":"10.1016\/j.vaccine.2008.06.021_bib7","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/jnci\/88.15.1068","article-title":"Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease","volume":"88","author":"Munoz","year":"1996","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"10.1016\/j.vaccine.2008.06.021_bib8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa011688","article-title":"Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners","volume":"346","author":"Castellsague","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.021_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1086\/514052","article-title":"Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia","volume":"176","author":"Castellsague","year":"1997","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.021_bib10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.vaccine.2008.06.021_bib11","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1086\/521629","article-title":"The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study","volume":"196","author":"Giuliano","year":"2007","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2008.06.021_bib12","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/507432","article-title":"Prevalence of HPV infection among men: A systematic review of the literature","volume":"194","author":"Dunne","year":"2006","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2008.06.021_bib13","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1158\/1055-9965.EPI-06-0997","article-title":"Human papillomavirus prevalence and type distribution in male anogenital sites and semen","volume":"16","author":"Nielson","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.021_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1086\/381395","article-title":"Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men","volume":"189","author":"Weaver","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.021_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jviromet.2007.12.010","article-title":"Reliability of sample collection and laboratory testing for HPV Detection in Men","volume":"149","author":"Flores","year":"2008","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2008.06.021_bib16","doi-asserted-by":"crossref","unstructured":"Giuliano AR, Lu B, Nielson C, et al. Age Specific Prevalence, Incidence, and Duration of Human Papillomavirus Infections Among a Cohort of 290 US Men. J Infect Dis. 2008, in press.","DOI":"10.1086\/591095"},{"key":"10.1016\/j.vaccine.2008.06.021_bib17","unstructured":"Nielson CM, Dunne EF, Abrahamsen M, Harris R, Giuliano AR. Associations between male anogenital HPV infection and circumcision vary by anatomic site sample. Abstract PS8-44. 24th International Papillomavirus Conference and Clinical Workshop. Beijing, China, November 2007. (Abstracts book)."},{"key":"10.1016\/j.vaccine.2008.06.021_bib18","unstructured":"Giuliano AR, Lazcano E, Villa LL, et al. Factors associated with HPV detection among men internationally: The HIM Study. Abstract 8B-04 24th International Papillomavirus Conference and Clinical Workshop. Beijing, China, November 2007. (Abstracts book)."},{"key":"10.1016\/j.vaccine.2008.06.021_bib19","doi-asserted-by":"crossref","unstructured":"Giuliano AR, Lazcano E, Villa LL, et al. The Human Papillomavirus Infection in Men (HIM) Study: HPV Prevalence and Type-Distribution among Men Residing in Brazil, Mexico, and the US. Cancer Epidemiol Biomarkers Prev. 2008, in press.","DOI":"10.1158\/1055-9965.EPI-08-0151"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.021_bib20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/infdis\/170.3.682","article-title":"Detection of high-risk human papillomavirus in the cervix and semen of sex partners","volume":"170","author":"Kyo","year":"1994","journal-title":"J Infect Dis"},{"issue":"8435","key":"10.1016\/j.vaccine.2008.06.021_bib21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0140-6736(85)91724-6","article-title":"Increased risk of cervical neoplasia in consorts of men with penile condylomata acuminata","volume":"1","author":"Campion","year":"1985","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2008.06.021_bib22","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/521192","article-title":"Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students","volume":"196","author":"Partridge","year":"2007","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.021_bib23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/341782","article-title":"Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study","volume":"186","author":"Giuliano","year":"2002","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.021_bib24","first-page":"240","article-title":"Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study","volume":"70","author":"Van Doornum","year":"1994","journal-title":"Genitourin Med"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.021_bib25","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1086\/516505","article-title":"Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women","volume":"176","author":"Svare","year":"1997","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2008.06.021_bib26","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1258\/0956462011923615","article-title":"Seroepidemiology of low and high oncogenic risk types of human papillomavirus in a predominantly male cohort of STD clinic patients","volume":"12","author":"Slavinsky","year":"2001","journal-title":"Int J STD AIDS"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.021_bib27","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1086\/315364","article-title":"Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions","volume":"181","author":"Hagensee","year":"2000","journal-title":"J Infect Dis"},{"issue":"9574","key":"10.1016\/j.vaccine.2008.06.021_bib28","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","article-title":"Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials","volume":"369","author":"Joura","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.021_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bpobgyn.2005.10.007","article-title":"Worldwide burden of gynaecological cancer: the size of the problem","volume":"20","author":"Sankaranarayanan","year":"2006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.vaccine.2008.06.021_bib30","unstructured":"Rotmensch J, Yamada SD. Neoplasms of the Vulva and Vagina. In: Kufe DW, Pollock RE, Weichselbaum RR, Bast JrR, Gansler TSHJFea, editors. Holland-Frei Cancer Medicine. 6th ed. Hamilton, Ontario: B.C. Decker, Inc, 2003."},{"key":"10.1016\/j.vaccine.2008.06.021_bib31","unstructured":"SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute, 2003."},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.021_bib32","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ygyno.2005.02.012","article-title":"Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients","volume":"97","author":"Van Seters","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.06.021_bib33","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.AOG.0000187301.76283.7f","article-title":"Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women","volume":"106","author":"Jones","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.06.021_bib34","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/01.pas.0000213291.96401.48","article-title":"The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN)","volume":"30","author":"Srodon","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.vaccine.2008.06.021_bib35","doi-asserted-by":"crossref","unstructured":"Sideri M, Jones RW, Heller DS, Haefner H, Neill S, Preti M, et al. Comment on the Article: Srodon M, Stoler MH, Baber GB, et al. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN) Am J Surg Pathol. 2006; 30:1513\u20131518. Am J Surg Pathol 2007; 31(9):1452\u20134.","DOI":"10.1097\/PAS.0b013e31804c9883"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.021_bib36","first-page":"807","article-title":"Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee","volume":"50","author":"Sideri","year":"2005","journal-title":"J Reprod Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.021_bib37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.pgp.0000189238.19027.df","article-title":"Pathologic audit of 164 consecutive cases of vulvar intraepithelial neoplasia","volume":"25","author":"Scurry","year":"2006","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.06.021_bib38","first-page":"393","article-title":"Vulval intraepithelial neoplasia: current perspectives","volume":"22","author":"Jones","year":"2001","journal-title":"Eur J Gynaecol Oncol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.06.021_bib39","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1097\/PAS.0b013e3180686d10","article-title":"Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination","volume":"31","author":"Skapa","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.021_bib40","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/01.AOG.0000210268.57527.a1","article-title":"Trends in the incidence of invasive and in situ vulvar carcinoma","volume":"107","author":"Judson","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2008.06.021_bib41","series-title":"Cancer Precursors: Epidemiology, Detection, and Prevention","first-page":"321","article-title":"Vulva and Vagina","author":"Madeleine","year":"2002"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.021_bib42","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/jnci\/93.11.824","article-title":"Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends","volume":"93","author":"Howe","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2008.06.021_bib43","unstructured":"Cancer Research UK. www.cancerresearchuk.org; Available at: www.cancerresearchuk.org. (last accessed: April 2008)."},{"key":"10.1016\/j.vaccine.2008.06.021_bib44","series-title":"SEER survival monograph: Cancer survival among adults: US SEER Program 1998\u20132001, Patient and Tumor Characteristics","article-title":"Cancer of the Vulva","author":"Kosary","year":"2007"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.021_bib45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00000478-199302000-00005","article-title":"Basaloid and warty carcinomas of the vulva. Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses","volume":"17","author":"Kurman","year":"1993","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.021_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0029-7844(95)00351-7","article-title":"Heterogeneous etiology of squamous carcinoma of the vulva","volume":"87","author":"Trimble","year":"1996","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.06.021_bib47","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1471-0528.1990.tb02502.x","article-title":"The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women","volume":"97","author":"Leibowitch","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.vaccine.2008.06.021_bib48","unstructured":"Nascimento C, Clifford G, DeVuyst H, Franceschi S. HPV prevalence and type distribution in carcinomas and intraepithelial neoplasia lesions of the vulva and vagina. The first in a series of meta-analysis in anogenital sites other than cervix. Abstract 4B-01. 24th International Papillomavirus Conference and Clinical Workshop. Beijing, China, November 2007. (Abstracts book)."},{"key":"10.1016\/j.vaccine.2008.06.021_bib49","unstructured":"Bosch FX, Vall\u00e8s X, Mu\u00f1oz N, Alejo M, Klaustermeier J, Lloveras B, et al. HPV contribution and genotype distribution in invasive cancer of the vulva and the vagina in 14 countries. Abstract PA2-06. 24th International Papillomavirus Conference and Clinical Workshop. Beijing, China, November 2007. (Abstracts book)."},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.021_bib50","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0029-7844(97)00467-5","article-title":"Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study","volume":"90","author":"Hildesheim","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"20","key":"10.1016\/j.vaccine.2008.06.021_bib51","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/jnci\/89.20.1516","article-title":"Cofactors with human papillomavirus in a population-based study of vulvar cancer","volume":"89","author":"Madeleine","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2008.06.021_bib52","unstructured":"Parkin DM, Whelan SLFJ, Teppo L, Thomas DB. Cancer Incidence in Five Continents, Volume VIII. Lyon: IARC Scientific Publications No. 155, 2003."},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.021_bib53","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1023\/A:1008433817832","article-title":"Descriptive epidemiology of vulvar and vaginal cancers in Vaud, Switzerland, 1974\u20131994","volume":"9","author":"Levi","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.vaccine.2008.06.021_bib54","unstructured":"Kosary CL. Cancer of the Vagina. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, editors. SEER survival monograph: Cancer survival among adults: US SEER Program 1998-2001, Patient and Tumor Characteristics. Bethesda, MD: National Cancer Institute, NIH, 2007."},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.021_bib55","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/oxfordjournals.aje.a116270","article-title":"Cigarette smoking and the risk of anogenital cancer","volume":"135","author":"Daling","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.021_bib56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/gyno.2001.6502","article-title":"A population-based study of squamous cell vaginal cancer: HPV and cofactors","volume":"84","author":"Daling","year":"2002","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.021_bib57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ije\/19.1.4","article-title":"Oral contraceptive use and risk of invasive cervical cancer","volume":"19","author":"Brinton","year":"1990","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.021_bib58","first-page":"1934","article-title":"Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites","volume":"61","author":"Carter","year":"2001","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.021_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0090-8258(90)90010-I","article-title":"Case-control study of in situ and invasive carcinoma of the vagina","volume":"38","author":"Brinton","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.vaccine.2008.06.021_bib60","series-title":"Cancer Epidemiology and Prevention","first-page":"1117","article-title":"Cancer of the vulva and vagina","author":"Daling","year":"1996"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.021_bib61","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cncr.20365","article-title":"Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer","volume":"101","author":"Daling","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2008.06.021_bib62","doi-asserted-by":"crossref","unstructured":"Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006 21;24 (Suppl. 3):S11\u2013S25.","DOI":"10.1016\/j.vaccine.2006.05.111"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.021_bib63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00384-005-0777-7","article-title":"HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis","volume":"21","author":"Varnai","year":"2006","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.vaccine.2008.06.021_bib64","unstructured":"IARC. Cancer Incidence in Five Continents, Vol. IX. IARC Scientific Publications No.160. Lyon: IARC, 2007."},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.021_bib65","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaad.2005.05.007","article-title":"Penile cancer","volume":"54","author":"Micali","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.06.021_bib66","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/archotol.124.9.951","article-title":"The National Cancer Data Base report on cancer of the head and neck","volume":"124","author":"Hoffman","year":"1998","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"7","key":"10.1016\/j.vaccine.2008.06.021_bib67","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.22963","article-title":"Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?","volume":"110","author":"Sturgis","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.vaccine.2008.06.021_bib68","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.amjoto.2006.11.012","article-title":"Human papillomavirus in oral squamous cells carcinoma in a population of 75 Brazilian patients","volume":"28","author":"Soares","year":"2007","journal-title":"Am J Otolaryngol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.021_bib69","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.oraloncology.2007.02.005","article-title":"Human papillomavirus infection and oral cancer: A case-control study in Montreal, Canada","volume":"44","author":"Pintos","year":"2008","journal-title":"Oral Oncol"},{"issue":"19","key":"10.1016\/j.vaccine.2008.06.021_bib70","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-control study of human papillomavirus and oropharyngeal cancer","volume":"356","author":"D'Souza","year":"2007","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.vaccine.2008.06.021_bib71","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jnci\/djg107","article-title":"Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study","volume":"95","author":"Herrero","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.vaccine.2008.06.021_bib72","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1258\/0956462981921143","article-title":"An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle","volume":"9","author":"Maw","year":"1998","journal-title":"Int J STD AIDS"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.021_bib73","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/513966","article-title":"Cervical intraepithelial neoplasia, anogenital cancer, and other cancer types in women after hospitalization for condylomata acuminata","volume":"175","author":"Friis","year":"1997","journal-title":"J Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2008.06.021_bib74","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.vaccine.2006.06.015","article-title":"Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"issue":"9296","key":"10.1016\/j.vaccine.2008.06.021_bib75","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(01)06886-6","article-title":"Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection","volume":"358","author":"Fenton","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.021_bib76","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1467-842X.2003.tb00813.x","article-title":"Sex in Australia: knowledge about sexually transmissible infections and blood-borne viruses in a representative sample of adults","volume":"27","author":"Grulich","year":"2003","journal-title":"Aust N Z J Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.021_bib77","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/OLQ.0b013e3181632d61","article-title":"Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999\u20132004","volume":"35","author":"Dinh","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2008.06.021_bib78","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/522863","article-title":"The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries","volume":"196","author":"Kjaer","year":"2007","journal-title":"J Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2008.06.021_bib79","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.021_bib80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1155\/S1064744901000278","article-title":"Female genital warts: global trends and treatments","volume":"9","author":"Gall","year":"2001","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2008.06.021_bib81","unstructured":"Centers for Disease Control and Prevention. Centers for Disease Control and Prevention 2008. Available at: http:\/\/www.cdc.gov\/ (last accessed: April 2008)."},{"key":"10.1016\/j.vaccine.2008.06.021_bib82","unstructured":"Health Protection Agency. Health Protection Agency, UK 2008 April Available at: http:\/\/www.hpa.org.uk\/ (last accessed: April 2008)."},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.021_bib83","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/375074","article-title":"The health and economic burden of genital warts in a set of private health plans in the United States","volume":"36","author":"Insinga","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.021_bib84","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2165\/00019053-200523110-00004","article-title":"Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature","volume":"23","author":"Insinga","year":"2005","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.021_bib85","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1185\/030079906X99972","article-title":"Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK","volume":"22","author":"Brown","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.021_bib86","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.1711650308","article-title":"Human papillomavirus 6, 11, and 16 in laryngeal papillomas","volume":"165","author":"Dickens","year":"1991","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.021_bib87","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1086\/313914","article-title":"Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle","volume":"31","author":"Armstrong","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.021_bib88","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2273.1991.tb00925.x","article-title":"Laryngeal papillomas: histomorphometric evaluation of multiple and solitary lesions","volume":"16","author":"Lindeberg","year":"1991","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.021_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/000348940611500101","article-title":"Recurrent respiratory papillomatosis","volume":"115","author":"Derkay","year":"2006","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.021_bib90","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jmv.20013","article-title":"Latent human papillomavirus infection is comparable in the larynx and trachea","volume":"72","author":"Abramson","year":"2004","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.021_bib91","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00020840-200404000-00006","article-title":"Human papillomavirus infection in the etiology of laryngeal carcinoma","volume":"12","author":"Hobbs","year":"2004","journal-title":"Curr Opin Otolaryngol Head Neck Surg"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08007469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08007469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T22:43:01Z","timestamp":1557787381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08007469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":91,"alternative-id":["S0264410X08007469"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.06.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}